The US Food & Drug Administration's delayed update on the manufacturing conditions at a US factory, which halted the release of millions of doses of the coronavirus vaccine of Johnson & Johnson worldwide, may come as early as today.

The US Food & Drug Administration’s delayed update on the manufacturing conditions at a US factory, which halted the release of millions of doses of the coronavirus vaccine of Johnson & Johnson worldwide, may come as early as today.

Published on

7 June 2021

That’s what a senior health official has told the Business Day newspaper. The decision was postponed from Friday to this week. J&J’s vaccines are central to the government’s rollout plans as they require only a single shot and are easier to store than the Pfizer/BioNTech double-shot vaccine, that is now being provided. Meanwhile, South Africa may receive an additional 480 000 Johnson & Johnson doses, but only if the US regulator finds it to be uncontaminated.

Merentia Van Der Vent

Merentia joined the media world in 1996 and in 2001, she took her first steps in the broadcasting world. In her free time, she likes to go on adventures in the city. She also likes to learn new dances, not that she is any good at that.